Visiting Professor of Clinical Pharmacology
- Chief Executive Officer, Oxford Academic Health Science Network
- Consultant Stroke Physician OUH
My work focuses on developing and evaluating treatments that can reduce brain damage in the first few hours after stroke, and developing better processes of care to deliver for stroke patients.
I have developed and evaluated the performance of stroke recognition instruments such as the Face Arm Speech Test (FAST) and Recognition of Stroke in the Emergency Room Scale (ROSIER) to improve early diagnosis of stroke by the public, ambulance paramedics and Emergency Department teams.
My work has evaluated the risks and benefits of thrombolysis in very elderly stroke patients 80 years or older, who are the population at highest risk of stroke.
In addition to my research in stroke my work more broadly seeks to understand the risks and benefits of drug therapies in older people.
Referral pathways for patients with TIA avoiding hospital admission: a scoping review.
Evans BA. et al, (2017), BMJ Open, 7
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.
Bath PM. et al, (2017), PLoS One, 12
Quantification of Serial Cerebral Blood Flow in Acute Stroke Using Arterial Spin Labeling.
Harston GW. et al, (2017), Stroke, 48, 123 - 130
Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial.
Muir KW. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 38 - 44
A systematic review of stroke recognition instruments in hospital and prehospital settings.
Rudd M. et al, (2016), Emerg Med J, 33, 818 - 822